The Wave Innovation Group is an Italian pharmaceutical company founded in 2016 by Dr. Salvatore Terrani, boasting extensive experience in the field of injectable medical devices based on hyaluronic acid (Class III) and the pharmaceutical sector.

The Wave Innovation Group was established to develop and commercialize innovative medical devices, created and developed in partnership with The Wave Research & Development. This collaboration enables cooperation with leading R&D companies and pharmaceutical firms worldwide.

The Wave Innovation Group manages the entire production process of injectable medical devices (Class III) at its own manufacturing hub, operating under ISO 13485 certification, with a strong focus on quality control.

The Wave Innovation Group owns the patents for the medical devices it commercializes, as well as those currently in development. This has allowed the company to build a diversified portfolio across multiple therapeutic areas, including pharmaceuticals, medical devices, dietary supplements, and healthcare products.

The company collaborates with two prestigious Italian universities: Luigi Vanvitelli University of Naples and STEBICEF – University of Palermo, which conduct preliminary studies for Phase I, II, and III research.

The Wave Innovation Group has a network of over 50 distributors worldwide, spanning Europe, Asia, Middle East and Latin America.